A Game of Numbers: the Stoichiometry of Antibody-mediated Neutralization of Flavivirus Infection

Overview

Journal Prog Mol Biol Transl Sci

Specialty Molecular Biology

Date 2015 Jan 18

PMID 25595803

Citations 32

Authors

Theodore C Pierson

Michael S Diamond

Affiliations

Soon will be listed here.

Abstract

The humoral response contributes to the protection against viral pathogens. Although antibodies have the potential to inhibit viral infections via several mechanisms, an ability to neutralize viruses directly may be particularly important. Neutralizing antibody titers are commonly used as predictors of protection from infection, especially in the context of vaccine responses and immunity. Despite the simplicity of the concept, how antibody binding results in virus inactivation is incompletely understood despite decades of research. Flaviviruses have been an attractive system in which to seek a structural and quantitative understanding of how antibody interactions with virions modulate infection because of the contribution of antibodies to both protection and pathogenesis. This review will present a stoichiometric model of antibody-mediated neutralization of flaviviruses and discuss how these concepts can inform the development of vaccines and antibody-based therapeutics.

Citing Articles

Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains.

Thiono D, Samaras D, Phan T, Zhu D, Shah R, Castillo I bioRxiv. 2025; .

PMID: 39990303 PMC: 11844416. DOI: 10.1101/2024.07.18.604114.

Viral infection and antiviral immunity in the oral cavity.

Hickman H, Moutsopoulos N Nat Rev Immunol. 2024; .

PMID: 39533045 DOI: 10.1038/s41577-024-01100-x.

T Cell Surveillance during Cutaneous Viral Infections.

Pei L, Hickman H Viruses. 2024; 16(5).

PMID: 38793562 PMC: 11126121. DOI: 10.3390/v16050679.

Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination.

Munt J, Henein S, Adams C, Young E, Hou Y, Conrad H Cell Host Microbe. 2023; 31(11):1850-1865.e5.

PMID: 37909048 PMC: 11221912. DOI: 10.1016/j.chom.2023.10.004.

Antiviral neutralizing antibodies: from in vitro to in vivo activity.

Burton D Nat Rev Immunol. 2023; 23(11):720-734.

PMID: 37069260 PMC: 10108814. DOI: 10.1038/s41577-023-00858-w.

References

Mozdzanowska K, Feng J, Eid M, Zharikova D, Gerhard W . Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components. Virology. 2006; 352(2):418-26. DOI: 10.1016/j.virol.2006.05.008. View

Yauch L, Shresta S . Dengue virus vaccine development. Adv Virus Res. 2013; 88:315-72. DOI: 10.1016/B978-0-12-800098-4.00007-6. View

Cherrier M, Kaufmann B, Nybakken G, Lok S, Warren J, Chen B . Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 2009; 28(20):3269-76. PMC: 2771083. DOI: 10.1038/emboj.2009.245. View

Peiris J, Gordon S, Unkeless J, PORTERFIELD J . Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature. 1981; 289(5794):189-91. DOI: 10.1038/289189a0. View

Halstead S, Mahalingam S, Marovich M, Ubol S, Mosser D . Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. 2010; 10(10):712-22. PMC: 3057165. DOI: 10.1016/S1473-3099(10)70166-3. View

Rodrigo W, Block O, Lane C, Sukupolvi-Petty S, Goncalvez A, Johnson S . Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype. Virology. 2009; 394(2):175-82. PMC: 2783259. DOI: 10.1016/j.virol.2009.09.024. View

Morrey J, Siddharthan V, Olsen A, Wang H, Julander J, Hall J . Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model. Antimicrob Agents Chemother. 2007; 51(7):2396-402. PMC: 1913249. DOI: 10.1128/AAC.00147-07. View

Kaufmann B, Rossmann M . Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes Infect. 2010; 13(1):1-9. PMC: 3014442. DOI: 10.1016/j.micinf.2010.09.005. View

Carrington C, Auguste A . Evolutionary and ecological factors underlying the tempo and distribution of yellow fever virus activity. Infect Genet Evol. 2012; 13:198-210. DOI: 10.1016/j.meegid.2012.08.015. View

10.

Fibriansah G, Tan J, Smith S, de Alwis A, Ng T, Kostyuchenko V . A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med. 2014; 6(3):358-71. PMC: 3958310. DOI: 10.1002/emmm.201303404. View

11.

Cockburn J, Navarro Sanchez M, Fretes N, Urvoas A, Staropoli I, Kikuti C . Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. Structure. 2012; 20(2):303-14. DOI: 10.1016/j.str.2012.01.001. View

12.

DULBECCO R, Vogt M, Strickland A . A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology. 1956; 2(2):162-205. DOI: 10.1016/0042-6822(56)90017-4. View

13.

Gach J, Leaman D, Zwick M . Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules. Curr Top Med Chem. 2011; 11(24):2997-3021. DOI: 10.2174/156802611798808505. View

14.

Bothner B, Dong X, Bibbs L, Johnson J, Siuzdak G . Evidence of viral capsid dynamics using limited proteolysis and mass spectrometry. J Biol Chem. 1998; 273(2):673-6. DOI: 10.1074/jbc.273.2.673. View

15.

Nybakken G, Oliphant T, Johnson S, Burke S, Diamond M, Fremont D . Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature. 2005; 437(7059):764-9. PMC: 7095628. DOI: 10.1038/nature03956. View

16.

Gromowski G, Barrett N, Barrett A . Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol. 2008; 82(17):8828-37. PMC: 2519678. DOI: 10.1128/JVI.00606-08. View

17.

Pantophlet R . Antibody epitope exposure and neutralization of HIV-1. Curr Pharm Des. 2010; 16(33):3729-43. DOI: 10.2174/138161210794079182. View

18.

Lok S, Kostyuchenko V, Nybakken G, Holdaway H, Battisti A, Sukupolvi-Petty S . Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol. 2008; 15(3):312-7. DOI: 10.1038/nsmb.1382. View

19.

Thompson B, Moesker B, Smit J, Wilschut J, Diamond M, Fremont D . A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog. 2009; 5(5):e1000453. PMC: 2679195. DOI: 10.1371/journal.ppat.1000453. View

20.

Zhou T, Zhu J, Yang Y, Gorman J, Ofek G, Srivatsan S . Transplanting supersites of HIV-1 vulnerability. PLoS One. 2014; 9(7):e99881. PMC: 4084637. DOI: 10.1371/journal.pone.0099881. View